Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Upgrades Concentriq for Modern Diagnostic Pathology

Proscia
By Author Proscia | June 17, 2021

In this article from Clinical Lab Products Magazine (CLP), Melanie Hamilton-Basich explored the recent upgrades to Proscia’s Concentriq® digital pathology platform.

“Pathology is under more pressure than ever before,” says David West, CEO of Proscia. “We’ve enhanced Concentriq to provide laboratories with the robust capabilities needed to accelerate adoption, helping them to better operate in the new normal and improve patient outcomes. In doing so, we’re also advancing pathology’s computational future by empowering laboratories to tap into data-driven approaches.”

Our website uses cookies. By using this site, you agree to its use of cookies.